Literature DB >> 24937452

Histone H4 Lys 20 methyltransferase SET8 promotes androgen receptor-mediated transcription activation in prostate cancer.

Lushuai Yao1, Yanyan Li2, Fengxia Du2, Xiao Han1, Xiaohua Li2, Yuanjie Niu3, Shancheng Ren4, Yingli Sun5.   

Abstract

Histone methylation status in different lysine residues has an important role in transcription regulation. The effect of H4K20 monomethylation (H4K20me1) on androgen receptor (AR)-mediated gene transcription remains unclear. Here we show that AR agonist stimulates the enrichment of H4K20me1 and SET8 at the promoter of AR target gene PSA in an AR dependent manner. Furthermore, SET8 is crucial for the transcription activation of PSA. Co-immunoprecipitation analyses demonstrate that SET8 interacts with AR. Therefore, we conclude that SET8 is involved in AR-mediated transcription activation, possibly through its interaction with AR and H4K20me1 modification.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen receptor; H4K20me1; Histone methylation; SET8; Transcription activation

Mesh:

Substances:

Year:  2014        PMID: 24937452     DOI: 10.1016/j.bbrc.2014.06.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.

Authors:  Nana Zheng; Xiangpeng Dai; Zhiwei Wang; Wenyi Wei
Journal:  Cell Cycle       Date:  2016-09-20       Impact factor: 4.534

2.  Distinct developmental phenotypes result from mutation of Set8/KMT5A and histone H4 lysine 20 in Drosophila melanogaster.

Authors:  Aaron T Crain; Stephen Klusza; Robin L Armstrong; Priscila Santa Rosa; Brenda R S Temple; Brian D Strahl; Daniel J McKay; A Gregory Matera; Robert J Duronio
Journal:  Genetics       Date:  2022-05-31       Impact factor: 4.402

3.  Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.

Authors:  Melina Mitsiogianni; Ioannis Anestopoulos; Sotiris Kyriakou; Dimitrios T Trafalis; Rodrigo Franco; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Invest New Drugs       Date:  2021-05-08       Impact factor: 3.850

4.  Overview on the complexity of androgen receptor-targeted therapy for prostate cancer.

Authors:  Ammad Ahmad Farooqi; Fazlul H Sarkar
Journal:  Cancer Cell Int       Date:  2015-02-04       Impact factor: 5.722

5.  Relationship between epigenetic changes in Wnt antagonists and acute leukemia.

Authors:  Hua-Rong Zhou; Hai-Ying Fu; Dan-Sen Wu; Yuan-Yuan Zhang; Si-Han Huang; Cong-Jie Chen; Jian-Guo Yan; Jin-Long Huang; Jian-Zhen Shen
Journal:  Oncol Rep       Date:  2017-03-15       Impact factor: 3.906

6.  Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.

Authors:  Melina Mitsiogianni; Dimitrios T Trafalis; Rodrigo Franco; Vasilis Zoumpourlis; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Eur J Nutr       Date:  2020-03-25       Impact factor: 5.614

7.  SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.

Authors:  Zhiwei Wang; Xiangpeng Dai; Jiateng Zhong; Hiroyuki Inuzuka; Lixin Wan; Xiaoning Li; Lixia Wang; Xiantao Ye; Liankun Sun; Daming Gao; Lee Zou; Wenyi Wei
Journal:  Nat Commun       Date:  2015-12-15       Impact factor: 14.919

Review 8.  The emerging role of lysine methyltransferase SETD8 in human diseases.

Authors:  Ciro Milite; Alessandra Feoli; Monica Viviano; Donatella Rescigno; Agostino Cianciulli; Amodio Luca Balzano; Antonello Mai; Sabrina Castellano; Gianluca Sbardella
Journal:  Clin Epigenetics       Date:  2016-09-22       Impact factor: 6.551

9.  Differential effect of estradiol and bisphenol A on Set8 and Sirt1 expression in prostate cancer.

Authors:  Kevin Burton; Lisa Shaw; Lisa M Morey
Journal:  Toxicol Rep       Date:  2015-02-17

10.  A functional single nucleotide polymorphism of SET8 is prognostic for breast cancer.

Authors:  Ben Liu; Xining Zhang; Fengju Song; Qun Liu; Hongji Dai; Hong Zheng; Ping Cui; Lina Zhang; Wei Zhang; Kexin Chen
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.